

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 7.48451877 |
| 2 | cytidine catabolic process (GO:0006216) | 7.48451877 |
| 3 | cytidine deamination (GO:0009972) | 7.48451877 |
| 4 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.67993344 |
| 5 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.48290167 |
| 6 | DNA deamination (GO:0045006) | 6.39060327 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 5.57078929 |
| 8 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 5.06958677 |
| 9 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.75459298 |
| 10 | actin nucleation (GO:0045010) | 4.73455213 |
| 11 | ATP synthesis coupled proton transport (GO:0015986) | 4.72749437 |
| 12 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.72749437 |
| 13 | regulation of chronic inflammatory response (GO:0002676) | 4.47958541 |
| 14 | sequestering of actin monomers (GO:0042989) | 4.45442207 |
| 15 | regulation of activation of Janus kinase activity (GO:0010533) | 4.12833398 |
| 16 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.05261305 |
| 17 | cytolysis (GO:0019835) | 3.98379349 |
| 18 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.95826324 |
| 19 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.89475818 |
| 20 | viral transcription (GO:0019083) | 3.82949767 |
| 21 | respiratory electron transport chain (GO:0022904) | 3.73790000 |
| 22 | positive regulation of B cell differentiation (GO:0045579) | 3.73403654 |
| 23 | electron transport chain (GO:0022900) | 3.70277268 |
| 24 | protein neddylation (GO:0045116) | 3.67131864 |
| 25 | negative T cell selection (GO:0043383) | 3.66948184 |
| 26 | T cell migration (GO:0072678) | 3.66562212 |
| 27 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.62404614 |
| 28 | positive T cell selection (GO:0043368) | 3.61855346 |
| 29 | translational termination (GO:0006415) | 3.60673599 |
| 30 | regulation of regulatory T cell differentiation (GO:0045589) | 3.56533333 |
| 31 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.46368552 |
| 32 | cotranslational protein targeting to membrane (GO:0006613) | 3.43856124 |
| 33 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.43452948 |
| 34 | protein targeting to ER (GO:0045047) | 3.43070426 |
| 35 | positive regulation of tolerance induction (GO:0002645) | 3.42186906 |
| 36 | translational elongation (GO:0006414) | 3.41409266 |
| 37 | regulation of T cell chemotaxis (GO:0010819) | 3.41194927 |
| 38 | positive regulation of T cell chemotaxis (GO:0010820) | 3.41194927 |
| 39 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.37406307 |
| 40 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.37406307 |
| 41 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.35791119 |
| 42 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.28700849 |
| 43 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.26852451 |
| 44 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.26607478 |
| 45 | positive regulation of cell killing (GO:0031343) | 3.25931682 |
| 46 | maturation of SSU-rRNA (GO:0030490) | 3.25859961 |
| 47 | protein localization to endoplasmic reticulum (GO:0070972) | 3.21894233 |
| 48 | positive thymic T cell selection (GO:0045059) | 3.19541016 |
| 49 | proteasome assembly (GO:0043248) | 3.17226576 |
| 50 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.14471431 |
| 51 | regulation of T cell tolerance induction (GO:0002664) | 3.14045184 |
| 52 | behavioral response to nicotine (GO:0035095) | 3.14000769 |
| 53 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.12024406 |
| 54 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.11623212 |
| 55 | negative regulation of T cell apoptotic process (GO:0070233) | 3.09051678 |
| 56 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.06211978 |
| 57 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.06069317 |
| 58 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.04023076 |
| 59 | transmission of nerve impulse (GO:0019226) | 3.03639006 |
| 60 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.02821457 |
| 61 | DNA demethylation (GO:0080111) | 3.00345849 |
| 62 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.99142922 |
| 63 | positive regulation of T cell apoptotic process (GO:0070234) | 2.98228891 |
| 64 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.91623644 |
| 65 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.91623644 |
| 66 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.91623644 |
| 67 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.91007635 |
| 68 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.90860760 |
| 69 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.90860760 |
| 70 | hydrogen ion transmembrane transport (GO:1902600) | 2.90814687 |
| 71 | negative regulation of viral genome replication (GO:0045071) | 2.89806784 |
| 72 | ribosomal small subunit biogenesis (GO:0042274) | 2.89495838 |
| 73 | activated T cell proliferation (GO:0050798) | 2.88685519 |
| 74 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.87772818 |
| 75 | regulation of cell killing (GO:0031341) | 2.86015958 |
| 76 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.85518656 |
| 77 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.81863103 |
| 78 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.79588995 |
| 79 | regulation of B cell differentiation (GO:0045577) | 2.78924267 |
| 80 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.78900721 |
| 81 | proton transport (GO:0015992) | 2.78459752 |
| 82 | cellular protein complex disassembly (GO:0043624) | 2.77323956 |
| 83 | cellular response to interleukin-15 (GO:0071350) | 2.77199964 |
| 84 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.76929123 |
| 85 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.75593130 |
| 86 | T cell receptor signaling pathway (GO:0050852) | 2.75493118 |
| 87 | protein complex biogenesis (GO:0070271) | 2.75225800 |
| 88 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.74796450 |
| 89 | termination of RNA polymerase III transcription (GO:0006386) | 2.74796450 |
| 90 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.74415841 |
| 91 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.74415841 |
| 92 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 2.73746290 |
| 93 | viral life cycle (GO:0019058) | 2.73316221 |
| 94 | hydrogen transport (GO:0006818) | 2.72164889 |
| 95 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.71882056 |
| 96 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.70487954 |
| 97 | eosinophil chemotaxis (GO:0048245) | 2.70392767 |
| 98 | response to interferon-beta (GO:0035456) | 2.70336874 |
| 99 | negative regulation of oxidoreductase activity (GO:0051354) | 2.70327940 |
| 100 | thymic T cell selection (GO:0045061) | 2.70155978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.07796478 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.62724817 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.45029814 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.35083011 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.28893432 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.17353922 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.17073749 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.05379041 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.95710248 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.86627463 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.86259349 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.83125882 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.83116919 |
| 14 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.76075616 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.71233011 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.43241977 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.36392797 |
| 18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.12694846 |
| 19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.10468532 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.09621801 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.09034927 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.94647997 |
| 23 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.91294494 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 1.77080255 |
| 25 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.77008381 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.76158780 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.72110810 |
| 28 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.65854949 |
| 29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.64757784 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.62295529 |
| 31 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.54445695 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.46095590 |
| 33 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.45994850 |
| 34 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.45243797 |
| 35 | GATA3_26560356_Chip-Seq_TH2_Human | 1.42330501 |
| 36 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40957888 |
| 37 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.40465287 |
| 38 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.38653566 |
| 39 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.38205049 |
| 40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.38020298 |
| 41 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.37424856 |
| 42 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.36395671 |
| 43 | EWS_26573619_Chip-Seq_HEK293_Human | 1.34643422 |
| 44 | AR_20517297_ChIP-Seq_VCAP_Human | 1.33014947 |
| 45 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.31877993 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31288171 |
| 47 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.30368462 |
| 48 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.30258456 |
| 49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27909258 |
| 50 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24236166 |
| 51 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.21844231 |
| 52 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.21508666 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21036337 |
| 54 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.20661727 |
| 55 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.20526700 |
| 56 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.20526700 |
| 57 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.19836762 |
| 58 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.19708198 |
| 59 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19284698 |
| 60 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18080244 |
| 61 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.17352793 |
| 62 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16506384 |
| 63 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16308819 |
| 64 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.14302071 |
| 65 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.13557530 |
| 66 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12463892 |
| 67 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.12385769 |
| 68 | NCOR_22424771_ChIP-Seq_293T_Human | 1.12351659 |
| 69 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.11325032 |
| 70 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.10869322 |
| 71 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.09190749 |
| 72 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.08227883 |
| 73 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07904751 |
| 74 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.05286078 |
| 75 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04552858 |
| 76 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04552858 |
| 77 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.04264080 |
| 78 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02227212 |
| 79 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.01723399 |
| 80 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.01031312 |
| 81 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.01020366 |
| 82 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.00265864 |
| 83 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.00228726 |
| 84 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.99451291 |
| 85 | ERA_21632823_ChIP-Seq_H3396_Human | 0.99353520 |
| 86 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.97955437 |
| 87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96897424 |
| 88 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.93808725 |
| 89 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.93551365 |
| 90 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.93186422 |
| 91 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92816402 |
| 92 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92348323 |
| 93 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.91434166 |
| 94 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.91293638 |
| 95 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.89922254 |
| 96 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.89658937 |
| 97 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.89647241 |
| 98 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.88375373 |
| 99 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88332673 |
| 100 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.87737140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.28815532 |
| 2 | MP0009785_altered_susceptibility_to | 3.17027184 |
| 3 | MP0002102_abnormal_ear_morphology | 3.05729691 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.72646171 |
| 5 | MP0009333_abnormal_splenocyte_physiolog | 2.60177925 |
| 6 | MP0001873_stomach_inflammation | 2.40480520 |
| 7 | MP0002166_altered_tumor_susceptibility | 2.40102880 |
| 8 | MP0009379_abnormal_foot_pigmentation | 2.33491918 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.31524794 |
| 10 | MP0005645_abnormal_hypothalamus_physiol | 2.19541998 |
| 11 | MP0000685_abnormal_immune_system | 2.06572393 |
| 12 | MP0002006_tumorigenesis | 2.03149867 |
| 13 | MP0003878_abnormal_ear_physiology | 1.92334718 |
| 14 | MP0005377_hearing/vestibular/ear_phenot | 1.92334718 |
| 15 | MP0001800_abnormal_humoral_immune | 1.88415780 |
| 16 | MP0005000_abnormal_immune_tolerance | 1.85914525 |
| 17 | MP0006072_abnormal_retinal_apoptosis | 1.85133450 |
| 18 | MP0008872_abnormal_physiological_respon | 1.83554218 |
| 19 | MP0005387_immune_system_phenotype | 1.79483386 |
| 20 | MP0001790_abnormal_immune_system | 1.79483386 |
| 21 | MP0006082_CNS_inflammation | 1.77105176 |
| 22 | MP0005025_abnormal_response_to | 1.76331074 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.74158400 |
| 24 | MP0005084_abnormal_gallbladder_morpholo | 1.72718897 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.71238772 |
| 26 | MP0005551_abnormal_eye_electrophysiolog | 1.70580016 |
| 27 | MP0004147_increased_porphyrin_level | 1.70129713 |
| 28 | MP0002723_abnormal_immune_serum | 1.66557534 |
| 29 | MP0002420_abnormal_adaptive_immunity | 1.66089236 |
| 30 | MP0004142_abnormal_muscle_tone | 1.65774486 |
| 31 | MP0002837_dystrophic_cardiac_calcinosis | 1.63112985 |
| 32 | MP0001905_abnormal_dopamine_level | 1.60926942 |
| 33 | MP0001819_abnormal_immune_cell | 1.59434966 |
| 34 | MP0001919_abnormal_reproductive_system | 1.55244222 |
| 35 | MP0006292_abnormal_olfactory_placode | 1.55070328 |
| 36 | MP0003866_abnormal_defecation | 1.53740813 |
| 37 | MP0001485_abnormal_pinna_reflex | 1.53402449 |
| 38 | MP0002876_abnormal_thyroid_physiology | 1.50385281 |
| 39 | MP0002277_abnormal_respiratory_mucosa | 1.49404327 |
| 40 | MP0004145_abnormal_muscle_electrophysio | 1.48058347 |
| 41 | MP0008877_abnormal_DNA_methylation | 1.46410282 |
| 42 | MP0003646_muscle_fatigue | 1.46121768 |
| 43 | MP0003567_abnormal_fetal_cardiomyocyte | 1.42784364 |
| 44 | MP0005389_reproductive_system_phenotype | 1.41993386 |
| 45 | MP0005646_abnormal_pituitary_gland | 1.39405416 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.35107814 |
| 47 | MP0003786_premature_aging | 1.31787901 |
| 48 | MP0001984_abnormal_olfaction | 1.30202120 |
| 49 | MP0003787_abnormal_imprinting | 1.28599225 |
| 50 | MP0004742_abnormal_vestibular_system | 1.27662217 |
| 51 | MP0000716_abnormal_immune_system | 1.26519667 |
| 52 | MP0002163_abnormal_gland_morphology | 1.25858348 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.25692586 |
| 54 | MP0001986_abnormal_taste_sensitivity | 1.25021361 |
| 55 | MP0002653_abnormal_ependyma_morphology | 1.23059656 |
| 56 | MP0006276_abnormal_autonomic_nervous | 1.21501159 |
| 57 | MP0002405_respiratory_system_inflammati | 1.20472900 |
| 58 | MP0002398_abnormal_bone_marrow | 1.18041219 |
| 59 | MP0000372_irregular_coat_pigmentation | 1.15577659 |
| 60 | MP0005075_abnormal_melanosome_morpholog | 1.10861825 |
| 61 | MP0002272_abnormal_nervous_system | 1.10310783 |
| 62 | MP0002234_abnormal_pharynx_morphology | 1.06680008 |
| 63 | MP0005410_abnormal_fertilization | 1.06426439 |
| 64 | MP0003436_decreased_susceptibility_to | 1.05808841 |
| 65 | MP0001968_abnormal_touch/_nociception | 1.05057240 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.04881725 |
| 67 | MP0002736_abnormal_nociception_after | 1.03786859 |
| 68 | MP0000703_abnormal_thymus_morphology | 1.02635696 |
| 69 | MP0001501_abnormal_sleep_pattern | 0.99760293 |
| 70 | MP0000689_abnormal_spleen_morphology | 0.98286921 |
| 71 | MP0005253_abnormal_eye_physiology | 0.98211209 |
| 72 | MP0009745_abnormal_behavioral_response | 0.93146110 |
| 73 | MP0002429_abnormal_blood_cell | 0.92478844 |
| 74 | MP0003045_fibrosis | 0.92058244 |
| 75 | MP0002733_abnormal_thermal_nociception | 0.90364746 |
| 76 | MP0010155_abnormal_intestine_physiology | 0.88856036 |
| 77 | MP0009764_decreased_sensitivity_to | 0.88516480 |
| 78 | MP0008469_abnormal_protein_level | 0.88290018 |
| 79 | MP0001542_abnormal_bone_strength | 0.88124885 |
| 80 | MP0002722_abnormal_immune_system | 0.87680756 |
| 81 | MP0003195_calcinosis | 0.86795393 |
| 82 | MP0002160_abnormal_reproductive_system | 0.86601246 |
| 83 | MP0003448_altered_tumor_morphology | 0.85712869 |
| 84 | MP0003011_delayed_dark_adaptation | 0.85136605 |
| 85 | MP0006036_abnormal_mitochondrial_physio | 0.84855857 |
| 86 | MP0001970_abnormal_pain_threshold | 0.83826979 |
| 87 | MP0003880_abnormal_central_pattern | 0.83255445 |
| 88 | MP0002693_abnormal_pancreas_physiology | 0.82314432 |
| 89 | MP0005379_endocrine/exocrine_gland_phen | 0.80649519 |
| 90 | MP0001348_abnormal_lacrimal_gland | 0.79894265 |
| 91 | MP0005166_decreased_susceptibility_to | 0.78624090 |
| 92 | MP0002638_abnormal_pupillary_reflex | 0.77937942 |
| 93 | MP0008995_early_reproductive_senescence | 0.77611594 |
| 94 | MP0004885_abnormal_endolymph | 0.76447661 |
| 95 | MP0001963_abnormal_hearing_physiology | 0.76002897 |
| 96 | MP0009763_increased_sensitivity_to | 0.73374402 |
| 97 | MP0000026_abnormal_inner_ear | 0.71488452 |
| 98 | MP0001663_abnormal_digestive_system | 0.70202512 |
| 99 | MP0002419_abnormal_innate_immunity | 0.69819430 |
| 100 | MP0009643_abnormal_urine_homeostasis | 0.69031295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 4.63091998 |
| 2 | Hypoproteinemia (HP:0003075) | 4.36223430 |
| 3 | T lymphocytopenia (HP:0005403) | 4.07126068 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.03518808 |
| 5 | Mitochondrial inheritance (HP:0001427) | 3.99891865 |
| 6 | Increased hepatocellular lipid droplets (HP:0006565) | 3.84350602 |
| 7 | Abnormality of T cell number (HP:0011839) | 3.78510074 |
| 8 | Renal Fanconi syndrome (HP:0001994) | 3.74189460 |
| 9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.66913043 |
| 10 | IgG deficiency (HP:0004315) | 3.59413161 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.50004275 |
| 12 | Hepatocellular necrosis (HP:0001404) | 3.47095262 |
| 13 | Increased CSF lactate (HP:0002490) | 3.46858278 |
| 14 | Lipid accumulation in hepatocytes (HP:0006561) | 3.44730047 |
| 15 | Progressive macrocephaly (HP:0004481) | 3.36717043 |
| 16 | Severe combined immunodeficiency (HP:0004430) | 3.33762878 |
| 17 | Acute encephalopathy (HP:0006846) | 3.33198409 |
| 18 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.17693129 |
| 19 | Increased intramyocellular lipid droplets (HP:0012240) | 3.10854833 |
| 20 | Increased IgM level (HP:0003496) | 3.02421924 |
| 21 | Hepatic necrosis (HP:0002605) | 3.00605180 |
| 22 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.98838448 |
| 23 | Reticulocytopenia (HP:0001896) | 2.98555163 |
| 24 | Pancreatic cysts (HP:0001737) | 2.96361573 |
| 25 | 3-Methylglutaconic aciduria (HP:0003535) | 2.90378621 |
| 26 | Exertional dyspnea (HP:0002875) | 2.83430891 |
| 27 | Thyroiditis (HP:0100646) | 2.78119166 |
| 28 | Autoimmune hemolytic anemia (HP:0001890) | 2.73458024 |
| 29 | Optic disc pallor (HP:0000543) | 2.71925325 |
| 30 | Abnormality of midbrain morphology (HP:0002418) | 2.71523345 |
| 31 | Molar tooth sign on MRI (HP:0002419) | 2.71523345 |
| 32 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.69917948 |
| 33 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.66717173 |
| 34 | Abolished electroretinogram (ERG) (HP:0000550) | 2.65934508 |
| 35 | Abnormality of B cell number (HP:0010975) | 2.65810987 |
| 36 | B lymphocytopenia (HP:0010976) | 2.65783261 |
| 37 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.61109844 |
| 38 | Abnormal albumin level (HP:0012116) | 2.59583892 |
| 39 | Hypoalbuminemia (HP:0003073) | 2.59583892 |
| 40 | Congenital stationary night blindness (HP:0007642) | 2.59544838 |
| 41 | Cerebral edema (HP:0002181) | 2.59535334 |
| 42 | Abnormality of T cells (HP:0002843) | 2.59300811 |
| 43 | Increased muscle lipid content (HP:0009058) | 2.55439432 |
| 44 | Combined immunodeficiency (HP:0005387) | 2.52211823 |
| 45 | Abnormal drinking behavior (HP:0030082) | 2.48651888 |
| 46 | Polydipsia (HP:0001959) | 2.48651888 |
| 47 | Tubular atrophy (HP:0000092) | 2.46413631 |
| 48 | Pancreatic fibrosis (HP:0100732) | 2.46157836 |
| 49 | Abnormal number of erythroid precursors (HP:0012131) | 2.43155781 |
| 50 | Attenuation of retinal blood vessels (HP:0007843) | 2.43126664 |
| 51 | Nephronophthisis (HP:0000090) | 2.42283920 |
| 52 | Pancytopenia (HP:0001876) | 2.40028568 |
| 53 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.39502177 |
| 54 | Decreased central vision (HP:0007663) | 2.36077767 |
| 55 | Increased serum lactate (HP:0002151) | 2.35914964 |
| 56 | True hermaphroditism (HP:0010459) | 2.35136155 |
| 57 | Generalized aminoaciduria (HP:0002909) | 2.33829625 |
| 58 | Constricted visual fields (HP:0001133) | 2.33347011 |
| 59 | Abnormality of renal resorption (HP:0011038) | 2.31630610 |
| 60 | Encephalitis (HP:0002383) | 2.31146761 |
| 61 | Medial flaring of the eyebrow (HP:0010747) | 2.28744154 |
| 62 | Abnormality of the prostate (HP:0008775) | 2.25457497 |
| 63 | Abnormality of eosinophils (HP:0001879) | 2.23235556 |
| 64 | Abnormality of the renal cortex (HP:0011035) | 2.22596670 |
| 65 | Chronic diarrhea (HP:0002028) | 2.19370267 |
| 66 | Stomatitis (HP:0010280) | 2.17383605 |
| 67 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.14596511 |
| 68 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.14596511 |
| 69 | Glycosuria (HP:0003076) | 2.11970765 |
| 70 | Abnormality of urine glucose concentration (HP:0011016) | 2.11970765 |
| 71 | Macrocytic anemia (HP:0001972) | 2.10782473 |
| 72 | Lactic acidosis (HP:0003128) | 2.08450433 |
| 73 | Pendular nystagmus (HP:0012043) | 2.02525654 |
| 74 | Absent thumb (HP:0009777) | 2.02007849 |
| 75 | Abnormality of the renal medulla (HP:0100957) | 1.97377634 |
| 76 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.93809503 |
| 77 | Hyperphosphaturia (HP:0003109) | 1.93456335 |
| 78 | Exercise intolerance (HP:0003546) | 1.92359409 |
| 79 | Dyschromatopsia (HP:0007641) | 1.91435584 |
| 80 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.90122312 |
| 81 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.90122312 |
| 82 | Ketosis (HP:0001946) | 1.89624389 |
| 83 | Asplenia (HP:0001746) | 1.89327526 |
| 84 | Lethargy (HP:0001254) | 1.88709017 |
| 85 | Polyuria (HP:0000103) | 1.87024874 |
| 86 | Respiratory failure (HP:0002878) | 1.87011212 |
| 87 | Leukodystrophy (HP:0002415) | 1.84249056 |
| 88 | Ketoacidosis (HP:0001993) | 1.82217212 |
| 89 | Stenosis of the external auditory canal (HP:0000402) | 1.80465288 |
| 90 | Reduced antithrombin III activity (HP:0001976) | 1.79122957 |
| 91 | Chronic sinusitis (HP:0011109) | 1.78788438 |
| 92 | Respiratory difficulties (HP:0002880) | 1.76642946 |
| 93 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.75621008 |
| 94 | Myokymia (HP:0002411) | 1.74581642 |
| 95 | Hypoplasia of the ulna (HP:0003022) | 1.73881004 |
| 96 | Abnormality of DNA repair (HP:0003254) | 1.69968019 |
| 97 | Hypoplasia of the uterus (HP:0000013) | 1.69765757 |
| 98 | Pulmonary infiltrates (HP:0002113) | 1.69403996 |
| 99 | Abnormality of macular pigmentation (HP:0008002) | 1.69327318 |
| 100 | Pigmentary retinal degeneration (HP:0001146) | 1.69246849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.03284177 |
| 2 | KDR | 4.40374840 |
| 3 | TESK2 | 3.23416317 |
| 4 | MAP4K1 | 3.11008474 |
| 5 | ZAK | 3.08417964 |
| 6 | TIE1 | 2.84619003 |
| 7 | TLK1 | 2.66453684 |
| 8 | VRK2 | 2.61804076 |
| 9 | BCKDK | 2.60156922 |
| 10 | MAP4K2 | 2.36157994 |
| 11 | TAOK3 | 2.14644812 |
| 12 | WNK4 | 2.12810367 |
| 13 | GRK1 | 2.09473471 |
| 14 | MAP3K11 | 2.00060069 |
| 15 | TESK1 | 1.94049082 |
| 16 | ADRBK2 | 1.93574954 |
| 17 | VRK1 | 1.84980044 |
| 18 | TEC | 1.81901363 |
| 19 | ITK | 1.72488735 |
| 20 | MAP3K12 | 1.65579868 |
| 21 | MST4 | 1.62562879 |
| 22 | NUAK1 | 1.57631122 |
| 23 | LIMK1 | 1.41844320 |
| 24 | FRK | 1.36967419 |
| 25 | FES | 1.35667362 |
| 26 | GRK6 | 1.32289185 |
| 27 | PINK1 | 1.32009522 |
| 28 | PASK | 1.31166552 |
| 29 | SCYL2 | 1.28755044 |
| 30 | PIK3CG | 1.22879014 |
| 31 | DAPK2 | 1.22277695 |
| 32 | MAP2K6 | 1.15041261 |
| 33 | NME1 | 1.14452732 |
| 34 | BTK | 1.01869891 |
| 35 | PRKCQ | 0.99804015 |
| 36 | STK39 | 0.99727001 |
| 37 | SYK | 0.98888130 |
| 38 | WNK3 | 0.95518157 |
| 39 | DAPK1 | 0.94235354 |
| 40 | LCK | 0.90140921 |
| 41 | BMPR1B | 0.89901147 |
| 42 | DYRK2 | 0.86357883 |
| 43 | CDK19 | 0.83667067 |
| 44 | CSNK1G3 | 0.80156695 |
| 45 | ZAP70 | 0.79551027 |
| 46 | TNK2 | 0.78171295 |
| 47 | CAMKK2 | 0.77930298 |
| 48 | INSRR | 0.76579336 |
| 49 | GRK7 | 0.74507127 |
| 50 | MAP3K4 | 0.72661229 |
| 51 | MUSK | 0.72525061 |
| 52 | MAP2K7 | 0.72175506 |
| 53 | MAPKAPK3 | 0.71034063 |
| 54 | IKBKB | 0.70176398 |
| 55 | CSK | 0.70065142 |
| 56 | BCR | 0.69656197 |
| 57 | RPS6KA5 | 0.69523181 |
| 58 | RPS6KA4 | 0.69032759 |
| 59 | ADRBK1 | 0.68540078 |
| 60 | PIM1 | 0.66004088 |
| 61 | OXSR1 | 0.63791751 |
| 62 | LYN | 0.63770291 |
| 63 | SRPK1 | 0.62466558 |
| 64 | MATK | 0.61615449 |
| 65 | CSNK1G1 | 0.61042320 |
| 66 | STK16 | 0.59854901 |
| 67 | DAPK3 | 0.56353302 |
| 68 | TRIM28 | 0.55194041 |
| 69 | MAPK13 | 0.54845908 |
| 70 | MYLK | 0.54062845 |
| 71 | CSNK1G2 | 0.52920058 |
| 72 | PIK3CA | 0.52546808 |
| 73 | CSNK1A1L | 0.50409422 |
| 74 | OBSCN | 0.48081907 |
| 75 | FYN | 0.45141100 |
| 76 | IGF1R | 0.44439050 |
| 77 | CSF1R | 0.42816522 |
| 78 | MINK1 | 0.41576312 |
| 79 | PRKCG | 0.40977084 |
| 80 | LRRK2 | 0.40169343 |
| 81 | PRKACA | 0.39548252 |
| 82 | NLK | 0.38285421 |
| 83 | PRKCA | 0.37749245 |
| 84 | IKBKE | 0.37491015 |
| 85 | KIT | 0.37411548 |
| 86 | PRKCH | 0.37136009 |
| 87 | CSNK2A2 | 0.35564549 |
| 88 | TAF1 | 0.34978767 |
| 89 | CAMK2A | 0.34211915 |
| 90 | CSNK2A1 | 0.32170534 |
| 91 | PLK3 | 0.31728472 |
| 92 | CAMKK1 | 0.30895019 |
| 93 | MAP3K5 | 0.29435064 |
| 94 | ROCK1 | 0.28572005 |
| 95 | TAOK2 | 0.27810364 |
| 96 | PIM2 | 0.26997124 |
| 97 | AURKA | 0.26063280 |
| 98 | GRK5 | 0.25786292 |
| 99 | TNIK | 0.25235802 |
| 100 | PRKCD | 0.24605787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.39088743 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.24226184 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.04706084 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.98963553 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.31246164 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.51276874 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.44337911 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.37894455 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.29463079 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.17398528 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.16505972 |
| 12 | Huntingtons disease_Homo sapiens_hsa05016 | 2.13571144 |
| 13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.08951188 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 2.05231926 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.03540655 |
| 16 | Protein export_Homo sapiens_hsa03060 | 2.02281304 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.01141724 |
| 18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.00994691 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.83417313 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.82746430 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.82039144 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.56338333 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.45704852 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43016900 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.29951162 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.24876201 |
| 27 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.24856554 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.21260284 |
| 29 | Basal transcription factors_Homo sapiens_hsa03022 | 1.15944576 |
| 30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08715706 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.07338739 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.04485814 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.00901068 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99524892 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.98738258 |
| 36 | Purine metabolism_Homo sapiens_hsa00230 | 0.98055414 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.95720568 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.93901202 |
| 39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.92590466 |
| 40 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91316245 |
| 41 | RNA degradation_Homo sapiens_hsa03018 | 0.91269075 |
| 42 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.88630975 |
| 43 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.88546596 |
| 44 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.88360779 |
| 45 | Measles_Homo sapiens_hsa05162 | 0.83973654 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80469767 |
| 47 | Mismatch repair_Homo sapiens_hsa03430 | 0.77079479 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.76823672 |
| 49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76620945 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.71986123 |
| 51 | Nicotine addiction_Homo sapiens_hsa05033 | 0.71370057 |
| 52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69538547 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68527669 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.67198438 |
| 55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.67102330 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66899624 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.66339266 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65886379 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64863761 |
| 60 | Olfactory transduction_Homo sapiens_hsa04740 | 0.64443598 |
| 61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.60064521 |
| 62 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.58626068 |
| 63 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58175728 |
| 64 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.56979218 |
| 65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.54210615 |
| 66 | Shigellosis_Homo sapiens_hsa05131 | 0.53394200 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.52653893 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52415103 |
| 69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51373318 |
| 70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.50955125 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49232125 |
| 72 | Base excision repair_Homo sapiens_hsa03410 | 0.48257470 |
| 73 | DNA replication_Homo sapiens_hsa03030 | 0.46836386 |
| 74 | Taste transduction_Homo sapiens_hsa04742 | 0.46763646 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.46445860 |
| 76 | Spliceosome_Homo sapiens_hsa03040 | 0.46201151 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42750199 |
| 78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41616883 |
| 79 | Viral myocarditis_Homo sapiens_hsa05416 | 0.40958711 |
| 80 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40786559 |
| 81 | Salmonella infection_Homo sapiens_hsa05132 | 0.37701672 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35714103 |
| 83 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34546816 |
| 84 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.34320961 |
| 85 | RNA transport_Homo sapiens_hsa03013 | 0.33018567 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.32814786 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31636147 |
| 88 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.30581944 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29257539 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26677597 |
| 91 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.26418580 |
| 92 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.24071529 |
| 93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.23847146 |
| 94 | Morphine addiction_Homo sapiens_hsa05032 | 0.23562387 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.23070931 |
| 96 | Salivary secretion_Homo sapiens_hsa04970 | 0.22943495 |
| 97 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.18597563 |
| 98 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.17873392 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.17430588 |
| 100 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.17243103 |

